Company Filing History:
Years Active: 2013
Title: **Longlin Yu: Innovator in Nucleic Acid Detection**
Introduction
Longlin Yu, an accomplished inventor based in Shaanxi, China, has made significant contributions to the field of nucleic acid detection. With one patent to his name, his research focuses on innovative methods to enhance the analysis of genetic material, providing valuable tools for the scientific community.
Latest Patents
Longlin Yu’s notable patent includes a method for utilizing test probes, common oligonucleotide chips, and a nucleic acid detection method, which allows for high-throughput detection of interesting bases or mutation sites in nucleic acid samples. This advancement employs linear test probe pairs, P1 and P2, which consist of flanking complementary sequences adjacent to targeted mutation sites. The invention is pivotal for re-sequencing target nucleic acid sequences, detecting and analyzing mutations, and genotyping pathogenic microorganisms.
Career Highlights
Currently, Longlin Yu is associated with Shaan Xi Lifegen Co., Ltd., where his innovative work continues to evolve. His expertise in the field of molecular biology and genetic analysis has positioned him as a leading force within the company, contributing to advancements in health and biotechnology.
Collaborations
Throughout his career, Longlin has collaborated with notable colleagues, including Chao Chen and Yitong Tang. These partnerships not only enrich his research but also foster a collaborative environment to innovate and refine techniques in nucleic acid detection.
Conclusion
Longlin Yu stands out as an influential inventor whose work in nucleic acid detection is paving the way for future innovations in the field. With his patent, he contributes to the understanding and analysis of genetic information, which holds great promise for advancements in health and disease research. His ongoing efforts at Shaan Xi Lifegen Co., Ltd. highlight the important intersection between technology and life sciences, cementing his role as a valued innovator in molecular biology.